Rapid test for the detection of influenza A and B with results in 15 minutes. The BioStar OIA FLU test provides a single result, with performance equivalent to 14-day viral culture.

Easy to Use

No additional equipment required

Multiple Specimen Types

Nasal aspirate, nasopharyngeal (NP) swab, throat swab and sputum.

Further Benefits of the BioStar OIA FLU Test

• The only rapid flu test with performance equivalent to 14-day viral culture.
• Reduce cost by eliminating unnecessary ancillary diagnostics
• Allow physician to prescribe appropriate antiviral medication
• Avoid unnecessary use of antibiotics

Data

Percent of Specimens Positive by the BioStar OIA FLU test or 14 Day Viral Culture

How to Choose Between
BioStar OIA FLU & FLU A/B

About Influenza

Influenza is responsible for approximately 114,000 hospitali-zations and 36,000 deaths per year.¹ Vaccination effectiveness varies among groups and is not 100% effective with any population.²

During the 2002-2003 flu season, influenza A viruses were reported more frequently than influenza B viruses (range 58% - 86%) in the New England, East North Central, Pacific, Mountain, and Mid-Atlantic regions, and influenza B viruses were reported more frequently than influenza A viruses (range 53% - 78%) in the West North Central, West South Central, South Atlantic, and East South Central regions.³

Bibliography & References

1. Covalciuc, K.; Webb, K.; and Carlson, C. Comparison of four clinical specimen types for detection of influenza a & b virus by optical immunoassay (FLU OIA test) and cell culture methods. J Clin Microbiol. 37, 12:3971-3974
2. Gander, R.M.; Reddy, S.T.; Patel, S.K.. Clinical Evaluation of the BioStar AB FLU OIA Test for Direct Detection of Influenza Types A and B in Respiratory Secretions. Abstr. 38th ICAAC Symposium., H59, 1998.
3. Hindiyeh, M; Goulding, C.; Morgan, H.; et al. Evaluation of BioStar Flu oia assay for rapid detection of influenza a and b viruses in respiratory specimens. Journal of Clinical Virology 17, 2: 119-126

CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2000;49 (No. RR-3)